Light AI Wellness Application Q3 2025 Launch
Light AI Inc., a healthcare technology company, has achieved key milestones in the development of its Wellness Strep A screening application. The company has introduced a multiplatform version of its mobile application and enhanced scalability and security for its AI systems. The AI powered software platform is currently undergoing internal user testing. The company is progressing with its commercialization efforts, with a targeted market availability for late 2025. The global AI healthcare market is projected to reach $110.6 billion by 2030.
Company on Track with Product Development and Commercialization
Light AI Inc. ("Light AI" or the "Company"), a healthcare technology company focused on developing artificial intelligence ("AI") health diagnostic and wellness solutions, is pleased to announce that it has achieved key internal milestones in the development of its Wellness Strep A screening application.
"We have made significant progress in the development of the Company's commercial platform since the beginning of 2025. These include the introduction of a multiplatform version of our mobile application with both Android and IOS smartphone and tablet support as well as robust scalability and security for our hyper-scale-based backend AI systems," stated Anthony Schaller, President and CTO of Light AI. "This significant product development investment positions the Company well as it transitions to its commercialization phase."
Commercialization Efforts and Market Outlook
The Company's AI-powered software platform is currently undergoing internal user testing by Light AI and its low and middle-income countries go-to-market partner, Tech Care For All. The Company continues to progress with its initial commercialization efforts for its Wellness Application, inclusive of potential targeted market-demonstration deployments with pharmacy companies. Commercial availability of the Company's Wellness Application remains targeted for late 2025.
The global AI healthcare market is projected to reach US$110.6 billion by 2030 from US$21.7 billion in 2025, at a CAGR of approximately 39% based upon adoption to new AI health and wellness solutions. The market is anticipated to grow due to the growing investments & funding by public-private organizations, the fast proliferation of AI in the healthcare industry, and the rising focus on developing human-aware AI systems. The market is experiencing growth due to increasing demand for enhanced services due to an unequal ratio between the healthcare workforce and patient numbers. However, inadequate IT infrastructure and unwillingness to adopt AI-based healthcare solutions in emerging economies are estimated to pose a challenge to market growth to be addressed.
About Light AI Inc.
Light AI Inc. is a technology company focused on developing artificial intelligence health screening and diagnostic solutions. Light AI is developing a technology platform that applies AI algorithms to smartphone images to identify diseases in seconds. Its patented, app-based solution requires no swabs, lab tests, or proprietary hardware. In pre-FDA validation studies, Light AI's algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS).
Light AI's technology offers a significant advancement in the accurate and timely identification of GAS pharyngitis, potentially reducing the incidence of serious complications. Light AI's commercial launch of its consumer-facing Wellness App initial offering is anticipated to be available in North America in Q3 2025.
For more information, please contact the Company at investors@light.ai.